Evidence map›Paper›PMID 40547074›Full record

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2025

Performance of CAD4TB artificial intelligence technology in TB screening programmes among the adult population in South Africa and Lesotho.

Nonhlanhla Nzimande, Keelin Murphy, Klaus Reither, Shannon Bosman, Irene Ayakaka, Tracy R Glass, Fiona Vanobberghen, Bart K M Jacobs, Aita Signorell, Jabulani Ncayiyana

Abstract read
In one paragraph

Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nonhlanhla NzimandeDivision of Public Health Medicine, School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Keelin MurphyRadboud University Medical Center, Nijmegen, the Netherlands.
Klaus ReitherSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Shannon BosmanCentre for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.
Irene AyakakaLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Tracy R GlassSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Fiona VanobberghenSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Bart K M JacobsDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Aita SignorellSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Jabulani NcayiyanaDivision of Public Health Medicine, School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is growing evidence of the performance accuracy and potential impact of Computer-Aided Diagnosis (CAD) products in TB-burdened settings. It remains unclear, however, which factors of populations and settings can affect CAD performance. We aimed to investigate the parameters affecting the performance accuracy of the two latest versions of CAD4TB in TB screening programmes in South Africa and Lesotho. We included participants recruited for the Lesotho National Prevalence Survey and the TB TRIAGE + ACCURACY studies, who underwent digital chest radiography and microbiological reference testing for TB. In total, 6,524 chest images were included in the analysis: 288 cases and 6,236 controls. CAD4TB versions 6 and 7 interpreted the X-ray images, and the performance of both versions was investigated. Threshold analyses were performed, as well as subgroup analyses, including age, X-ray hardware and HIV status. CAD4TB v7 showed overall improved performance accuracy compared to v6 (p < 0.01). The area under the ROC curve was 0.833 (95 % CI 0.808-0.859) for v6 and 0.865 (95 % CI 0.842-0.889) for v7. At 90 % sensitivity, v7 showed a higher specificity of 65 % compared to the 54 % achieved by v6. Both versions showed lower performance in the older age group (≥60 years) and individuals with a previous history of TB. The threshold required to achieve the same sensitivity or specificity varies notably across the two versions. CAD4TB performed well as a TB screening tool; however, factors such as software version, age, TB history and X-ray hardware should be considered in threshold determination and performance evaluation.

Indexed as

AlgorithmArtificial intelligenceCAD4TBchest X-raysTB screening

Identifiers

PMID40547074
PMCPMC12179731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.